NFKB1 and hyperuricemia: Collectively, however, these results suggest that the circulating metabolic profile within the serum content following TCDD exposure is likely contributing to the known immunomodulation by dioxins via inhibition of NF-κB activity with some potential lingering NF-κB activation resulting from COX-1 activity at sites of cell damage and hyperuricemia.